Status:
COMPLETED
Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors
Lead Sponsor:
Hanane EL KENZ
Conditions:
Sickle Cell Disease
Sickle Cell Trait
Eligibility:
All Genders
Phase:
NA
Brief Summary
Bearers of the sickle cell allele (S) are currently eligible for blood donations in Belgium. As blood donors are not tested for this allele, their heterozygous status is unknown. However, guidelines r...
Eligibility Criteria
Inclusion
- All patients with sickle cell disease within the CHU Brugmann and the Queen Fabiola Children's Hospital (HUDERF)
Exclusion
- None
Key Trial Info
Start Date :
February 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 3 2020
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT03405688
Start Date
February 13 2018
End Date
August 3 2020
Last Update
January 28 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020
2
HUDERF
Brussels, Belgium, 1020